|
As reported in a research article, a patient had residual shunt and iatrogenic coarctation of aorta after an amplatzer duct occluder was implanted.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|
|
The article, ¿a challenging interventional procedure: transcatheter closure of tubular patent ductus arteriosus in patients with pulmonary hypertension¿, was reviewed.The article presents a case study of an 3.5-year-old, 12kg patient with the following patent ductus arteriosus (pda) measurements: minimal ductus diameter = 7mm, ampulla diameter = 9mm, ductal length = 7mm.It was reported on an unknown date, a 10-8mm amplatzer duct occluder i was chosen for implant to occlude a pda.After the device was implanted, it was noted there was a residual shunt and iatrogenic coarctation of aorta.A decision was made to additionally implant a 10mm amplatzer muscular ventricular septal duct.The second device was implanted successfully.[the primary and corresponding author is ilker kemal yucel, department of pediatric cardiology, university of health sciences dr.Siyami ersek thoracic and cardiovascular surgery training and research hospital, istanbul, turkey, ilkerkemalyucel@yahoo.Com].Periprocedural complications included residual shunt and surgical intervention.
|